Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2005
12/21/2005EP1606630A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4)
12/21/2005EP1606396A2 Methods of promoting the differentiation of stem cells
12/21/2005EP1606307A1 ESTRIENO(3,2-b)/(3,4-c)PYRROLE DERIVATIVES USEFUL AS MODULATORS OF THE ESTROGEN RECEPTORS
12/21/2005EP1606284A1 Compositions useful as protein kinase inhibitors
12/21/2005EP1606237A1 2-(butyl-1-sulfonylamino)-n- 1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound
12/21/2005EP1605976A1 PHENYLCARBOXYL ACID AMIDES AND IK r CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA
12/21/2005EP1605964A1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE
12/21/2005EP1605947A1 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1450834B1 Allium sativum bulb absolutes and therapeutic or cosmetic uses
12/21/2005EP1432701B1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
12/21/2005EP1395558B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1389205B1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1363897B1 Antagonists of mcp-1 function and methods of use thereof
12/21/2005EP1282429A4 Pharmaceutical gel composition
12/21/2005EP1280567B1 Nitric oxide-releasing metallic medical devices
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1261625B1 Memno peptides, a process for their preparation and their use
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1180015B1 Generation of therapeutic microfoam
12/21/2005EP1144431B1 16-hydroxyestratrienes as selective estrogens
12/21/2005EP1125924B1 Intermediate for the synthesis of amlodipine, preparation process and corresponding utilization
12/21/2005EP1119581B1 USE OF A VECTOR EXPRESSING RB2/p130 FOR PREVENTION OR TREATMENT OF RESTENOSIS OR ATHEROSCLEROTIC PLAQUES
12/21/2005EP1102768B1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
12/21/2005EP1023059B1 Pharmaceutical preparations
12/21/2005EP0831807B1 Use of brefeldin a and derivatives thereof in the preparation of medicaments for the treatment of hyperplasia and related disorders
12/21/2005EP0579819B1 Novel pyridone derivative having an affinity for the angiotensine ii receptor
12/21/2005CN1711262A Imidazo[1, 5a]pyridine derivatives and methods for treating aldosterone mediated diseases
12/21/2005CN1711261A New imidazopyrdine derivatives, its preparation method and medicine composition containing same
12/21/2005CN1711260A Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
12/21/2005CN1711235A New phenyl-naphthalene derivatives, and preparation method and drug containing same
12/21/2005CN1232539C Match of organic medicine and beta-cyclodextrin derivative and its preparing process
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/21/2005CN1232293C Preparation of Chinese medicinal powder injecta for preventing and treating thrombosis obstruction disease
12/21/2005CN1232289C Medicine for treating cranial vascular disease
12/21/2005CN1232286C Medication for treating hemorrhoids and preparation method
12/21/2005CN1232283C Chinese drugs for treatment of coronary heart disease and angina pectoris
12/21/2005CN1232273C Medicine compositions for treating cardiovascular cerebralvascular disease, and its prepn. method
12/21/2005CN1232267C Medicine composition for treating cerebral vascular disease and its application
12/21/2005CN1232266C Chinese medicinal preparation for apoplexy and thoracic palsy and preparation thereof
12/21/2005CN1232251C Gingko lactone powder injection and its preparation method
12/21/2005CN1232246C Application of 4-methyl cyclopentadecanone in manufacture of medicine
12/20/2005US6977298 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/20/2005US6977270 Tocotrienolquinone cyclization product with an anti-hypercholesterol effect
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977263 Chemical compounds
12/20/2005US6977261 Treating osteoarthritis or rheumatoid arthritis
12/20/2005US6977255 8-Substituted 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-ones inhibitor of phosphoinositide (PI) 3- kinase, an enzyme that regulates platelet-adhesion (antithrombotic agent)
12/20/2005US6977158 Mammalian IAP gene family, primers, probes, and detection methods
12/20/2005US6977080 administering intrapericardially a neurotoxin; reducing the previously required daily antiarrhythmic drug, reducing need for pacemakers
12/20/2005US6977071 Use for treatment of inflammatory diseases, HIV-infection, angiogenisis and hematopoiesis-related disorders;
12/20/2005CA2329703C Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
12/20/2005CA2324324C Treatment of pulmonary hypertension
12/15/2005WO2005118623A1 Method and composition for treating angiogenesis and for preventing cancer progression and metastasis comprising a prostate secretory protein (psp94) family member
12/15/2005WO2005118619A1 Dipeptide exhibiting antihypertensive action
12/15/2005WO2005118576A1 Constrained himbacine analogs as thrombin receptor antagonists
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005117920A1 Agent for removing factor causing circulatory dysfunction
12/15/2005WO2005117901A1 Oral formulations of paricalcitol
12/15/2005WO2005117869A1 Combinations comprising (s)-amlodipine and a cholesteryl ester transfer protein inhibitor, and methods for reducing hypertension
12/15/2005WO2005097177A8 Use of collagenase to facilitate guide wire crossing in total arterial occlusions
12/15/2005WO2005070459A8 Method of continuing expression of vector repeatedly administered
12/15/2005US20050277691 Pravastatin pharmaceutical formulations and methods of their use
12/15/2005US20050277678 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent
12/15/2005US20050277673 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability
12/15/2005US20050277671 Benzimidazolone carboxylic acid derivatives
12/15/2005US20050277652 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277627 Colchinol derivatives as vascular damaging agents
12/15/2005US20050277606 Administering by direct injection into heart an expression vector comprising a nucleic acid sequence encoding AOP-1 operably linked to a promoter, wherein expression of nucleic acid sequence within cells of heart enhances production of AOP-1, protecting against myocardial cell death
12/15/2005US20050276893 Method for producing fat and/or solids from beans and compositions containing polyphenols
12/15/2005US20050276853 Chronotherapeutic dosage forms and methods of treatment using chronotherapy
12/15/2005CA2578806A1 Oral formulations of paricalcitol
12/15/2005CA2569881A1 Compositions comprising nebivolol
12/15/2005CA2568801A1 Agent for removing circulatory dysfunction factor
12/15/2005CA2568524A1 Modulators of muscarinic receptors
12/15/2005CA2568393A1 Methods for treating a mammal before, during and after cardiac arrest
12/15/2005CA2568159A1 Tetrahydro-imidazo [1,5-a] pyridin derivatives as aldosterone synthase inhibitors
12/15/2005CA2568158A1 Treatment of amyotrophic lateral sclerosis
12/15/2005CA2567901A1 Method and composition for treating angiogenesis and for preventing cancer progression and metastasis comprising a prostate secretory protein (psp94) family member
12/15/2005CA2562940A1 Methods of promoting cardiac cell proliferation
12/14/2005EP1605040A1 Monocyte-origin multipotent cell momc
12/14/2005EP1604984A1 Water-soluble phenylpyridazine derivative and medicine containing the same
12/14/2005EP1604983A1 Receptor antagonist
12/14/2005EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
12/14/2005EP1604979A1 2-oxo-1-pyrrolidine derivative and its pharmaceutical uses
12/14/2005EP1604669A1 Use of ATP analogues for treatment of cardiovascular diseases
12/14/2005EP1604664A1 Medicine for prevention of and treatment for arteriosclerosis and hypertension
12/14/2005EP1604651A1 Transdermal patches and methods for delivering testosterone
12/14/2005EP1603908A1 Quinazoline derivatives as tgf-beta inhibitors
12/14/2005EP1603884A2 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists.
12/14/2005EP1603606A2 Endovascular implant with an at least sectional active coating made of radjadone and/or a ratjadone derivative
12/14/2005EP1603587A1 Use of tumor endothelial markers 1, 9 and 17 to promote angiogenesis
12/14/2005EP1603573A2 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention
12/14/2005EP1603567A2 Tetracyclic benzamide derivatives and methods of use thereof
1 ... 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 ... 1595